Curis Lifesciences Limited was originally formed and registered as a Partnership Firm under the Partnership Act, 1932 in the name and style of 'M/s Loreto Pharmaceutacals', pursuant to a Deed of Partnership dated 2 June, 2010. Thereafter ' M/s Loreto Pharmaceutacals' was converted from Partnership Firm to a Private Limited Company as 'Curis Lifesciences Private Limited' and received a Certificate of Incorporation dated on March 23rd, 2016 issued by Registrar of Companies, Ahmedabad. Subsequently, Company was converted into a Public Limited Company and the name of the Company was changed from 'Curis Lifesciences Private Limited' to 'Curis Lifesciences Limited' vide certified incorporated upon the conversion dated August 9, 2024, issued by the Central Processing Centre, Manesar.
Company's business is related to manufacturing of pharmaceutical products for different markets globally as well as domestic. The business is majorly on product to product basis with different marketers. Company has commenced manufacturing facility in year 2017, hence, it has experience of more than 7 years in the current line of business of the Company. The manufacturing facility of the Company is installed with capacity to manufacture 138 Crore tables / year, 15.75 Crore Capsules / year, 1,080 Kilolitre Oral Liquid/ year, 270 Tons external preparation / year and 45 Tons sterile ophthalmic ointment / year. It deal in Pharmaceutical products like Tablets, Capsules, External Preparations, Oral Liquid ..., Sterile Ophthalmic Ointments etc.
The Company's past and present clientele includes renowned pharma marketers and manufactures namely Arova Pharma, Express Pharmaceuticals Private Limited, Angle Biogenics Private Limited, Centurion Healthcare Private Limited, Costcon Healthcare LLP, J.B. Chemical & Pharmaceuticals Limited, Venus international, Makers Laboratories Limited and Torikaa Pharmaceuticals Limited etc. pharmaceutical manufacturing facility are situated at Sanand GIDC-II in Ahmedabad district of Gujarat, which offers easy and convenient accessibility.
Company launched the IPO by raising a fresh issue of Rs 27.52 Crore and issued 21,50,000 equity shares of Rs 10 by way of IPO in Nov'25.
FAQs on Curis Lifesciences Ltd
1. Can I buy Curis Lifesciences Ltd from PL Capital? ›
Yes, you can invest in Curis Lifesciences Ltd shares directly through PL Capital. Our platform provides a seamless and secure way to buy, hold, and track Curis Lifesciences Ltd stock along with other leading companies listed on the NSE and BSE. Simply open a Demat and trading account with PL Capital, and you’ll be able to trade Curis Lifesciences Ltd as well as diversify your portfolio across equities, mutual funds, IPOs, and more.
2. Does Curis Lifesciences Ltd pay dividends? ›
Curis Lifesciences Ltd does not currently pay dividends. Investors in this case primarily benefit from capital appreciation, where the value of the stock may rise over time depending on business growth and market conditions.
3. What is the current share price of Curis Lifesciences Ltd ? ›
As of
11-Aug-2026 , 15:31:14 the share price for Curis Lifesciences Ltd. is ₹ 104.55 on the NSE (Note: Prices are dynamic and update frequently during market hours).
4. What is the 52-week high and low of Curis Lifesciences Ltd ? ›
The 52-week high and low of Curis Lifesciences Ltd share price is ₹ 83.6 - ₹ 147.9 as of
11-Aug-2026 , 15:31:14 .
Open Your Demat Account with PL Capital now
10 Lakh+ Active users
Award Winning research insights
No hidden charges
Start Stock SIP
Start SIP in Curis Lifesciences Ltd
Invest systematically in stocks with the PL Capital app
